Publikationen der ALS-Forschungsgruppe an der Charité The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegiaMeyer T, Münch C, Völkel H, Mehr The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosisMeyer T, Lenk U, Küther G, Mehr Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegiaMeyer T, Münch C, Völkel H, Mehr The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosisMeyer T, Lenk U, Küther G, Mehr Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis « Zurück 1 … 4 5 6 Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisLudolph AC, Dorst J, Dreyhaupt J, Mehr Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis Prognostic factors in ALS: a comparison between Germany and ChinaDorst J, Chen L, Rosenbohm A, Mehr Prognostic factors in ALS: a comparison between Germany and China GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosisSchumacher H, Meyer T, Prüss H. Mehr GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialLudolph AC, Schuster J, Dorst J, Mehr Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial Comprehensive analysis of the mutation spectrum in 301 German ALS familiesMüller K, Brenner D, Weydt P, Mehr Comprehensive analysis of the mutation spectrum in 301 German ALS families Therapeutic decision in ALS patients: cross-cultural differences and clinical implicationsAndersen PM, Kuzma-Kozakiewicz M, Keller J, Mehr Therapeutic decision in ALS patients: cross-cultural differences and clinical implications 1 2 3 … 8 Weiter »
